Signal active
Contact Information
Social
Primary Organization
2007
51-100
Biotechnology, Health Care, Therapeutics
Bio
Phil has over 20 years’ experience in biopharmaceutical R&D and has held senior operational and leadership roles in the development of novel antibody therapeutics. He began his career at the Glaxo Institute of Applied Pharmacology and GlaxoWellcome before gaining biologics expertise at Cambridge Antibody Technology (CAT) and PanGenetics. Phil has also held CSO positions in smaller venture-backed companies focused on the discovery and development of antibody therapeutics (Navion and SweetSpot Therapeutics) and was a co-founder at Nascient.
Prior to joining Crescendo, Phil was a VP at Kymab with particular responsibility for the scientific leadership of their most advanced development programme.
Phil holds a BPharm degree in pharmacy and a PhD in pharmacology, both from King’s College London.
Location
Cambridge, Cambridgeshire, United Kingdom, Europe
Jobs history
0
N/A
Educations
1
N/A
Profile Resume
Philip Bland-Ward is the Chief Development Officer (CDO) at Crescendo Biologics, based in Europe. With a background in Biotechnology, Philip Bland-Ward has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.